Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
Let's take a look at the biotech stocks awaiting FDA decisions in February. Supernus Pharmaceuticals Inc. (SUPN) The FDA decision on Supernus Pharma's SPN-830, an investigational apomorphine ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company's oral non-opioid pain medication, received Food and Drug Administration approval. The Boston company's stock rose 4.3% ...
An FDA recall on Lay's potato chips originally issued in December has been upgraded by the agency to its highest risk level. It appears that eggs can't stay out of the headlines as a recall on ...
“As a corporate entity, we understand the importance of supporting organisations like Transparency International PNG that are working tirelessly to bring about positive change in the fight against ...
The Food and Drug Administration just raised its recall of Lay’s Classic Potato Chips to the highest risk level. On Dec. 16, Frito-Lay issued a recall for 6,344 (13-ounce) bags of Lay’s ...
The Food and Drug Administration sometimes uses a program called the ... Ivan Troy: Yeah, it’s an issue of transparency. Tom Temin: Right. So then I guess someone could arrive at the conclusion, ...
Jan 29 (Reuters) - The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following ...
In the final days of the Biden Administration, the United States Food and Drug Administration (FDA) issued final guidance on Scientific Information on Unapproved Uses (SIUU), Communications From Firms ...
The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...
The U.S. Food and Drug Administration (“FDA”), in partnership ... and the company’s commitment to compliance, quality, and transparency. Companies will be well served by ensuring their ...
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression. Spravato is made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results